Form 4: Organovo Holdings Director Acquires Shares Through Restricted Stock Units

Director Douglas Jay Cohen acquired 19,607 shares of Organovo Holdings, Inc. through restricted stock units.

Summary

• On August 7, 2024, Douglas Jay Cohen, a director of Organovo Holdings, Inc., acquired 19,607 shares of common stock.
• The acquisition was in the form of restricted stock units (RSUs) granted at a price of $0.00.
• These RSUs will vest on the earlier of August 7, 2025, or the date of the next annual meeting of stockholders held by the Issuer in 2025, subject to acceleration in the event of a change of control.
• Following the transaction, Cohen directly owns 68,821 shares of common stock.
• Cohen also indirectly owns 1,000 shares through his son and 1,000 shares through his daughter.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of a director's share acquisition. The acquisition itself can be viewed slightly positively, but the document is primarily informational.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the restricted stock units is contingent on future events, including the annual meeting of stockholders and potential change of control.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a director's acquisition of shares, which is a common occurrence.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Organovo Holdings, Director, Share Acquisition, Restricted Stock Units, ONVO, Beneficial Ownership, Form 4